Related references
Note: Only part of the references are listed.Single or double embryo transfer? Decision-making process in patients participating in an oocyte donation program
Elisabet Clua et al.
GYNECOLOGICAL ENDOCRINOLOGY (2020)
Ovarian hyperstimulation syndrome following GnRH agonist trigger for final follicular maturation in a patient undergoing random start ovarian stimulation for egg-donation cycle with an inadvertent concomitant early pregnancy
Juan Castillo et al.
GYNECOLOGICAL ENDOCRINOLOGY (2020)
Do we need to measure progesterone in oocyte donation cycles? A retrospective analysis evaluating cumulative live birth rates and embryo quality
A. Racca et al.
HUMAN REPRODUCTION (2020)
Effect of oocyte donor stimulation on recipient outcomes: data from a US national donor oocyte bank
H. S. Hipp et al.
HUMAN REPRODUCTION (2020)
Ovarian stimulation for freeze-all IVF cycles: a systematic review
Yossi Mizrachi et al.
HUMAN REPRODUCTION UPDATE (2020)
Does LH suppression by progesterone-primed ovarian stimulation compared with GnRH antagonist affect live birth rate among oocyte recipients?
Francisca Martinez et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2020)
The effect of type of oral contraceptive pill and duration of use on fresh and cumulative live birth rates in IVF/ICSI cycles
Pedro Montoya-Botero et al.
HUMAN REPRODUCTION (2020)
Definition of a clinical strategy to enhance the efficacy, efficiency and safety of egg donation cycles with imported vitrified oocytes
Laura Rienzi et al.
HUMAN REPRODUCTION (2020)
Mild stimulation should be mandatory for oocyte donation
Guido Pennings
HUMAN REPRODUCTION (2020)
Efficiency and efficacy of vitrification in 35 654 sibling oocytes from donation cycles
D. Cornet-Bartolome et al.
HUMAN REPRODUCTION (2020)
Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial
R. Begueria et al.
HUMAN REPRODUCTION (2019)
Oocyte donor age has a significant impact on oocyte recipients' cumulative live-birth rate: a population-based cohort study
Rosemarie G. Hogan et al.
FERTILITY AND STERILITY (2019)
Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted reproductive technology
Sule Yildiz et al.
FERTILITY AND STERILITY (2019)
Is younger better? Donor age less than 25 does not predict more favorable outcomes after in vitro fertilization
Leigh A. Humphries et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2019)
How to perform a meta-analysis with R: a practical tutorial
Sara Balduzzi et al.
EVIDENCE-BASED MENTAL HEALTH (2019)
New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles
Sha Yu et al.
HUMAN REPRODUCTION (2018)
Impact of the levonorgestrel-releasing intrauterine device on controlled ovarian stimulation outcomes
Amanda J. Adeleye et al.
FERTILITY AND STERILITY (2018)
Impact of late-follicular phase elevated serum progesterone on cumulative live birth rates: is there a deleterious effect on embryo quality?
A. Racca et al.
HUMAN REPRODUCTION (2018)
ART in Europe, 2014: results generated from European registries by ESHRE
Ch. De Geyter et al.
HUMAN REPRODUCTION (2018)
Ethics of oocyte banking for third-party assisted reproduction: a systematic review
E. M. Kool et al.
HUMAN REPRODUCTION UPDATE (2018)
Revisiting the association between smoking and female fertility using the oocyte donation model
Thomas Freour et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2018)
Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013
Sara Crawford et al.
FERTILITY AND STERILITY (2017)
Effect of GnRHa ovulation trigger dose on follicular fluid characteristics and granulosa cell gene expression profiles
Thi Ngoc Lan Vuong et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2017)
Importance of a 5-versus 7-day pill-free interval in a GnRH antagonist protocol using corifollitropin alfa: a prospective cohort study in oocyte donors
Alicia Perez-Calvo et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2017)
Economic impact of ovarian stimulation with corifollitropin alfa versus conventional daily gonadotropins in oocyte donors: a randomized study
Maria Cruz et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2017)
Random-start ovarian stimulation in women desiring elective cryopreservation of oocytes
Nigel Pereira et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2017)
Reproductive outcomes in recipients are not associated with oocyte donor body mass index up to 28 kg/m2: a cohort study of 2722 cycles
Francisca Martinez et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2017)
Top quality blastocyst formation rates in relation to progesterone levels on the day of oocyte maturation in GnRH antagonist IVF/ICSI cycles
V. S. Vanni et al.
PLOS ONE (2017)
Comparison of two different dosage of GnRH agonist as ovulation trigger in oocyte donors: a randomized controled trial
Sonia Morales Zarcos et al.
JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA (2017)
Trends over 15 years in ART in Europe: an analysis of 6 million cycles
A. P. Ferraretti et al.
HUMAN REPRODUCTION OPEN (2017)
The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial
J. Dong et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2017)
Obstetric and perinatal complications in an oocyte donation programme. Is it time to limit the number of embryos to transfer?
Elisabet Clua et al.
GYNECOLOGICAL ENDOCRINOLOGY (2016)
Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study
Thi Ngoc Lan Vuong et al.
FERTILITY AND STERILITY (2016)
Investigating psychosocial attitudes, motivations and experiences of oocyte donors, recipients and egg sharers: a systematic review
Timothy Bracewell-Milnes et al.
HUMAN REPRODUCTION UPDATE (2016)
Anti-Mullerian hormone serum level and other markers associated with pregnancy outcome in oocyte donation
Anne-Sophie Delesalle et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2016)
Elevated Progesterone Levels on the Day of Oocyte Maturation May Affect Top Quality Embryo IVF Cycles
Bo Huang et al.
PLOS ONE (2016)
Six years' experience in ovum donation using vitrified oocytes: report of cumulative outcomes, impact of storage time, and development of a predictive model for oocyte survival rate
Ana Cobo et al.
FERTILITY AND STERILITY (2015)
Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization
Yanping Kuang et al.
FERTILITY AND STERILITY (2015)
Utrogestan as an Effective Oral Alternative for Preventing Premature Luteinizing Hormone Surges in Women Undergoing Controlled Ovarian Hyperstimulation for In Vitro Fertilization
Xiuxian Zhu et al.
MEDICINE (2015)
Comparison of starting ovarian stimulation on day 2 versus day 15 of the menstrual cycle in the same oocyte donor and pregnancy rates among the corresponding recipients of vitrified oocytes
Francisca Martinez et al.
FERTILITY AND STERILITY (2014)
Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles
Yanping Kuang et al.
FERTILITY AND STERILITY (2014)
Repetitive oocyte donation: a committee opinion
FERTILITY AND STERILITY (2014)
Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE
M. S. Kupka et al.
HUMAN REPRODUCTION (2014)
Effective method for emergency fertility preservation: random-start controlled ovarian stimulation
Hakan Cakmak et al.
FERTILITY AND STERILITY (2013)
Comparative analysis of fetal and neonatal outcomes of pregnancies from fresh and cryopreserved/thawed oocytes in the same group of patients
Paolo Emanuele Levi Setti et al.
FERTILITY AND STERILITY (2013)
Is AMH useful to reduce low ovarian response to GnRH antagonist protocol in oocyte donors?
Francisca Martinez et al.
GYNECOLOGICAL ENDOCRINOLOGY (2013)
IVF outcomes in obese donor oocyte recipients: a systematic review and meta-analysis
E. S. Jungheim et al.
HUMAN REPRODUCTION (2013)
How does vitrification affect oocyte viability in oocyte donation cycles? A prospective study to compare outcomes achieved with fresh versus vitrified sibling oocytes
M. Sole et al.
HUMAN REPRODUCTION (2013)
Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach
Simone L. Broer et al.
HUMAN REPRODUCTION UPDATE (2013)
Evaluation of the degree of satisfaction in oocyte donors using sustained-release FSH corifollitropin α
Antonio Requena et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2013)
Triggering ovulation with 250 μg or 500 μg of r-hCG in oocyte donors treated with antagonist protocol has no effect on the number of mature oocytes retrieved: a randomized clinical trial
Elisabet Clua et al.
GYNECOLOGICAL ENDOCRINOLOGY (2012)
Donor age is a major determinant of success of oocyte donation/recipient programme
Yueping Alex Wang et al.
HUMAN REPRODUCTION (2012)
Ovarian antral folliculogenesis during the human menstrual cycle: a review
Angela R. Baerwald et al.
HUMAN REPRODUCTION UPDATE (2012)
Triggering with GnRH agonist in oocyte-donation cycles: oestradiol monitoring is not necessary during ovarian stimulation
J. C. Castillo et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2012)
Anti-Mullerian hormone for the assessment of ovarian response in GnRH-antagonist-treated oocyte donors
Nikolaos P. Polyzos et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2012)
Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis
Daniel Bodri et al.
FERTILITY AND STERILITY (2011)
Anti-Mullerian hormone serum levels predict response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation
Ryan Riggs et al.
FERTILITY AND STERILITY (2011)
Anti-Mullerian hormone testing is useful for individualization of stimulation protocols in oocyte donors
Gary S. Nakhuda et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2011)
Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study
Daniel Bodri et al.
FERTILITY AND STERILITY (2010)
A prospective, randomized, controlled trial comparing three different gonadotropin regimens in oocyte donors: ovarian response, in vitro fertilization outcome, and analysis of cost minimization
Marco Melo et al.
FERTILITY AND STERILITY (2010)
Randomized, comparative pilot study of pituitary suppression with depot leuprorelin versus cetrorelix acetate 3 mg in gonadotropin stimulation protocols for oocyte donors
Fracisca Martinez et al.
FERTILITY AND STERILITY (2010)
Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial
Ana Cobo et al.
HUMAN REPRODUCTION (2010)
Antral follice counts (AFC) predict ovarian response and pregnancy outcomes in oocyte donation cycles
Alaina Vrontikis et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2010)
Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization outcome in an egg donation program
Marco Antonio Barreto Melo et al.
FERTILITY AND STERILITY (2009)
Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial
Anna Galindo et al.
GYNECOLOGICAL ENDOCRINOLOGY (2009)
Ovulation triggering with GnRH agonist vs. hCG in the same egg donor population undergoing donor oocyte cycles with GnRH antagonist: a prospective randomized cross-over trial
A. Sismanoglu et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2009)
GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study
M. Melo et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
The incidence of both serious and minor complications in young women undergoing oocyte donation
Kara N. Maxwell et al.
FERTILITY AND STERILITY (2008)
Prospective, randomized, comparative study of leuprorelin plus human menopausal gonadotropins versus ganirelix plus recombinant follicle-stimulating hormone in oocyte donors and pregnancy rates among the corresponding recipients
Francisca Martinez et al.
GYNECOLOGICAL ENDOCRINOLOGY (2008)
Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles
Daniel Bodri et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2008)
Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates
Belen Acevedo et al.
FERTILITY AND STERILITY (2006)
Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors:: a randomized clinical trial
D. Bodri et al.
HUMAN REPRODUCTION (2006)
GnRH agonist versus GnRH antagonist in oocyte donation cycles: a prospective randomized study
N Prapas et al.
HUMAN REPRODUCTION (2005)
Luteinizing hormone supplementation increases pregnancy rates in gonadotropin-releasing hormone antagonist donor cycles
B Acevedo et al.
FERTILITY AND STERILITY (2004)
GnRH antagonists followed by a decline in serum estradiol results in adverse outcomes in donor oocyte cycles
SR Lindheim et al.
HUMAN REPRODUCTION (2003)
Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence
J Tesarik et al.
HUMAN REPRODUCTION (2002)
Share Paper
